Sunday, May 12, 2019

Novartis AG is offering price discounts in negotiations with U.S. health insurers on its gene therapy for spinal muscular atrophy (SMA), a treatment that could cost more than a million dollars, but the gesture comes with strings attached.


from Reuters: Health News https://reut.rs/2Hao93E

Related Posts:

  • LATEST HEALTH NEWSIn at least 15 countries C-section use exceeds 40 per cent, researchers said from Health https://ift.tt/2OUjfwA … Read More
  • LATEST HEALTH NEWSA New Jersey jury on Thursday cleared Johnson & Johnson of liability in a case involving a woman who alleged that the company's talc-based products, including its baby powder, contain asbestos and caused her cancer. … Read More
  • LATEST HEALTH NEWSThe new research undercuts widely held beliefs about strenuous physical training and pregnancy from Health https://ift.tt/2pQAdhh … Read More
  • LATEST HEALTH NEWSThe relationship between the public and private healthcare systems in India is tenuous from Health https://ift.tt/2INyK3U … Read More
  • LATEST HEALTH NEWSAbbvie Inc said on Thursday it settled all patent disputes with Novartis AG, granting it a non-exclusive license to manufacture and sell a copycat version of blockbuster drug, Humira. from Reuters: Health News https://if… Read More

0 comments:

Post a Comment

Followers

Contact Form

Name

Email *

Message *

Popular Posts

FOLLOW BY EMAIL

Enter your email address:

Delivered by FeedBurner